Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
The melanocortin system is one of the most thoroughly mapped signaling networks in peptide pharmacology. It is organized around five G-protein-coupled receptors, designated MC1R through MC5R, together with a family of endogenous ligands cleaved from the precursor protein proopiomelanocortin (POMC). These melanocortin peptides, including alpha-melanocyte-stimulating hormone (alpha-MSH), are studied in preclinical models for roles that range from pigment-cell biology to central pathways governing energy balance. Because every receptor subtype couples to the cyclic AMP (cAMP) second-messenger cascade, the system provides a durable framework for structure-activity research.
This overview surveys three synthetic melanocortin-receptor peptides that appear frequently in laboratory literature: Melanotan-1, Melanotan-2, and PT-141. Each is discussed only in terms of its receptor targets and its molecular characteristics as a research reagent. Nothing here describes clinical outcomes or human application; these compounds are presented for research use only, not for human consumption. The intent is a clear comparative reference for investigators evaluating melanocortin agonists at the bench.
The Melanocortin System: Receptors and Signaling
Melanocortin receptors are among the smallest G-protein-coupled receptors and are distinguished by their shared coupling to the stimulatory G-protein that raises intracellular cAMP. Ligand activity is further tuned by endogenous antagonists such as agouti and agouti-related protein (AgRP), which makes the system a well-defined model for studying receptor agonism and selectivity.
The Five Melanocortin Receptors
Each subtype is defined by its tissue distribution and its principal research context. The localizations below reflect commonly reported laboratory attributes and are provided for comparison only.
| Receptor | Primary Research Localization | Commonly Studied Context |
|---|---|---|
| MC1R | Melanocytes | Melanin synthesis (melanogenesis) signaling in cultured cells |
| MC2R | Adrenal cortex | ACTH-driven steroidogenesis |
| MC3R | Central nervous system | Energy homeostasis and inflammation models |
| MC4R | Hypothalamus | Feeding behavior and energy balance in animal models |
| MC5R | Exocrine (sebaceous) tissue | Glandular secretion studies |
POMC-Derived Peptides and the cAMP Pathway
The natural melanocortin ligands, alpha-MSH, beta-MSH, gamma-MSH, and adrenocorticotropic hormone (ACTH), are all processed from POMC. Synthetic analogs are designed to resist enzymatic breakdown while preserving the core pharmacophore that engages the receptor. When an agonist binds, receptor activation elevates cAMP and downstream protein kinase A activity, a readout that laboratories use to quantify potency. This shared mechanism is why melanocortin agonists are typically compared by their receptor selectivity profiles rather than by any single functional endpoint.
Three Melanocortin-Receptor Peptides in Research
Melanotan-1
Melanotan-1 (also written as afamelanotide in some literature) is a linear analog of alpha-MSH. It is a tridecapeptide, meaning it carries 13 amino acid residues, and it was engineered for greater stability than the native hormone. In cultured melanocyte research it behaves as a potent MC1R agonist, where MC1R activation drives the cAMP-dependent melanogenesis pathway. Investigators reference it primarily in studies of pigment-cell signaling and receptor structure-activity relationships. Laboratory listings for this compound are available on the Melanotan-1 research page.
Melanotan-2
Melanotan-2 is a cyclic, lactam-bridged heptapeptide analog. In contrast to the receptor-focused profile of Melanotan-1, it is a non-selective agonist with reported activity across MC1R, MC3R, MC4R, and MC5R. Its compact cyclic architecture confers strong metabolic stability, which is one reason it serves as a common reference compound in broad melanocortin structure-activity studies. Reference material is catalogued on the Melanotan-2 research page.
PT-141
PT-141 (research designation bremelanotide) is a cyclic heptapeptide closely related to Melanotan-2. It is formally the deaminated, carboxyl-terminal analog in which the terminal amide of Melanotan-2 is replaced by a hydroxyl group, giving a free carboxylic acid. In receptor terms, PT-141 is characterized as an MC3R and MC4R agonist and is examined within central melanocortin-signaling research. It is frequently used as a benchmark ligand for those two subtypes. Documentation is provided on the PT-141 research page.
Comparative Molecular Profile
The identity table below summarizes the molecular characteristics most often cited for these three peptides. These values reflect commonly reported laboratory attributes and are provided for comparison only.
| Attribute | Melanotan-1 | Melanotan-2 | PT-141 |
|---|---|---|---|
| Class | Linear alpha-MSH analog | Cyclic (lactam) analog | Cyclic (lactam) analog |
| Sequence length | 13 residues | 7-residue cyclic core | 7-residue cyclic core |
| Molecular formula | C78H111N21O19 | C50H69N15O9 | C50H68N14O10 |
| Molecular weight (approx.) | 1646.9 g/mol | 1024.2 g/mol | 1025.2 g/mol |
| Primary receptor focus | MC1R | MC1R, MC3R, MC4R, MC5R | MC3R, MC4R |
| C-terminus | Amide | Amide | Carboxylic acid |
The progression from Melanotan-1 to the two cyclic peptides illustrates a central theme in melanocortin design: constraining the peptide backbone into a ring reduces its size, improves stability, and shifts the receptor selectivity profile. The single C-terminal difference between Melanotan-2 and PT-141 is a useful reminder that small chemical edits can meaningfully change how a compound distributes its activity across the receptor subtypes.
Evaluating Research-Grade Melanocortin Peptides
Receptor Selectivity and Assay Design
Because these compounds span a range from receptor-focused (Melanotan-1 at MC1R) to broadly non-selective (Melanotan-2), selectivity is a central variable in experimental design. Common bench approaches include cAMP accumulation assays in receptor-transfected cell lines and competition binding studies that quantify affinity at individual subtypes. Reference ligands such as PT-141 are often included to benchmark MC3R and MC4R responses. Anchoring every experiment to a defined receptor readout keeps interpretation aligned with the melanocortin literature and away from unsupported functional claims.
Purity, Documentation, and Reconstitution
Reliable data depend on well-characterized material. Before running an assay, researchers should confirm identity and purity, and understanding how to read the supporting paperwork is the first step; the certificate of analysis and purity primer explains the mass spectrometry and HPLC markers that matter most. Sourcing practices are equally important, and the supplier vetting guide outlines how to assess a vendor. For handling, lyophilized melanocortin peptides are typically reconstituted with bacteriostatic water; as a worked example, adding 2 mL of diluent to a 10 mg vial yields a 5 mg/mL stock. The bacteriostatic water reconstitution guide covers technique in detail, and the full catalog is available in the research peptide shop.
Frequently Asked Questions
What is the melanocortin system?
The melanocortin system is a signaling network made up of five G-protein-coupled receptors (MC1R through MC5R) and peptide ligands derived from proopiomelanocortin. In research it is studied for roles in pigment-cell biology, adrenal steroidogenesis, and central regulation of energy balance, with each receptor signaling through the cyclic AMP pathway.
Which receptors do Melanotan-1, Melanotan-2, and PT-141 target?
Melanotan-1 is studied primarily as an MC1R agonist. Melanotan-2 is a non-selective agonist reported to activate MC1R, MC3R, MC4R, and MC5R. PT-141 is characterized in research as an MC3R and MC4R agonist within the central melanocortin pathway.
How do these three peptides differ structurally?
Melanotan-1 is a linear peptide of 13 amino acids based on alpha-MSH. Melanotan-2 and PT-141 are smaller cyclic peptides built around a seven-residue lactam ring. PT-141 differs from Melanotan-2 mainly at the C-terminus, where an amide group is replaced by a carboxylic acid.
What is PT-141 in a research setting?
PT-141, also designated bremelanotide, is a cyclic melanocortin-receptor peptide investigated as an agonist at MC3R and MC4R. It is used as a reference ligand in studies of central melanocortin signaling and receptor structure-activity relationships.
Are melanocortin peptides approved for human use?
No. The peptides discussed here are laboratory research reagents. They are offered for research use only, not for human consumption, and are not intended for self-administration, diagnosis, or therapy.
How should research-grade melanocortin peptides be assessed for quality?
Investigators typically review a current certificate of analysis, confirm identity and purity by mass spectrometry and HPLC, and verify third-party or in-house documentation before use. Consistent lot documentation and transparent sourcing are the main indicators of a reliable research supply.
References and Further Reading
- Cone RD and colleagues. Reviews of the central melanocortin system and MC4R in energy homeostasis (University of Michigan and Vollum Institute). PubMed: melanocortin system MC4R Cone
- Hadley ME, Hruby VJ and colleagues. Design and structure-activity of superpotent cyclic alpha-MSH analogs (University of Arizona). PubMed: melanotan alpha-MSH analog Hruby
- Molecular cloning and characterization of melanocortin receptor subtypes. PubMed: melanocortin receptor cloning subtypes
- MC1R signaling and melanogenesis in melanocyte research. PubMed: MC1R melanogenesis signaling
- Proopiomelanocortin processing and melanocortin peptide biology. PubMed: proopiomelanocortin melanocortin peptides
- Pharmacology of bremelanotide at melanocortin receptors. PubMed: bremelanotide melanocortin receptor
- Melanocortin receptor coupling to cyclic AMP signaling. PubMed: melanocortin receptor cAMP signaling
